Скачать или смотреть The End of Colorectal Cancer Starts with Project Cure CRC

The Colorectal Cancer Alliance is making bold strides in its mission to put an end to the disease. Project Cure CRC, the Alliance's innovative research initiative, has awarded new grants, convened top scientists to spark breakthrough advancements at the Cure CRC Summit, and unveiled K-SPY, a groundbreaking multi-center platform trial for high-risk colorectal cancer cases.

Since its launch, Project Cure CRC has received 275 proposals, of which 22 have been approved totaling $10.5 million in awards.

“Colorectal cancer is the second deadliest cancer in the nation, yet it is grossly underfunded, causing a tremendous gap in the development of new treatments and therapies,” said Michael Sapienza, CEO of the Colorectal Cancer Alliance. “Project Cure CRC is committed to filling that gap and improving outcomes for the millions of people affected by this disease.”

Learn more at colorectalcancer.org/research